Screener
Rapport Therapeutics, Inc. RAPP Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Property and equipment, net | 2,337 | 2,976 |
| Operating lease right of use asset, net | 8,732 | 9,909 |
| Other assets | 1,057 | 985 |
| Total assets | $458,982 | $512,431 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $2,796 | $4,190 |
| Accrued expenses and other current liabilities | 23,155 | 12,104 |
Item 1. Financial Statements.
FAQ
- What is Rapport Therapeutics, Inc.'s total assets?
- Rapport Therapeutics, Inc. (RAPP) reported total assets of $458.98M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s total assets changed year-over-year?
- Rapport Therapeutics, Inc.'s total assets increased by 60.8% year-over-year, from $285.5M to $458.98M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s total assets?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s total assets has grown at a 81.6% compound annual growth rate (CAGR), from $155.42M to $512.43M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Rapport Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude